UBS AM’s IDEAYA Biosciences IDYA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.84M Buy
175,151
+1,027
+0.6% +$34.5K ﹤0.01% 1495
2025
Q4
$6.02M Sell
174,124
-27,319
-14% -$871K ﹤0.01% 1370
2025
Q3
$5.48M Sell
201,443
-71,217
-26% -$1.72M ﹤0.01% 1328
2025
Q2
$5.73M Sell
272,660
-30,485
-10% -$585K ﹤0.01% 1649
2025
Q1
$4.97M Sell
303,145
-20,141
-6% -$429K ﹤0.01% 1581
2024
Q4
$8.31M Buy
323,286
+4,790
+2% +$136K ﹤0.01% 1338
2024
Q3
$10.1M Buy
318,496
+6,219
+2% +$236K ﹤0.01% 1214
2024
Q2
$11M Buy
312,277
+80,759
+35% +$3.2M ﹤0.01% 1091
2024
Q1
$10.2M Sell
231,518
-42,583
-16% -$1.83M ﹤0.01% 986
2023
Q4
$9.75M Buy
274,101
+3,710
+1% +$111K ﹤0.01% 992
2023
Q3
$7.3M Buy
+270,391
New +$6.86M ﹤0.01% 1062
2023
Q1
Sell
-32,072
Closed -$583K 2694
2022
Q4
$583K Buy
32,072
+16,999
+113% +$286K ﹤0.01% 2117
2022
Q3
$225K Buy
15,073
+4,973
+49% +$64.6K ﹤0.01% 2573
2022
Q2
$139K Hold
10,100
﹤0.01% 2619
2022
Q1
$113K Hold
10,100
﹤0.01% 2731
2021
Q4
$239K Buy
+10,100
New +$235K ﹤0.01% 2732

Other funds holding IDYA